Zarxio
NDC Package 61314-246-71

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Zarxio is filgrastim is a man-made version of a certain natural substance made in your body. Marketed by Sandoz Inc., this product is identified by NDC 61314-246 and is authorized under FDA application BLA125553.

Identification & Billing

NDC Package Code
61314-246-71
Package Description
1 VIAL in 1 CARTON / 1 mL in 1 VIAL
Product Code
61314-246
11-Digit Billing Format
61314024671

Clinical Specifications

Proprietary Name
Zarxio
Dosage Form
-
Usage Information
Filgrastim is a man-made version of a certain natural substance made in your body. It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Filgrastim is given to people whose ability to make white blood cells is reduced (for instance, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation). It is also used in certain treatment procedures (such as bone marrow/stem cell transplant). This monograph is about the following filgrastim products: filgrastim, tbo-filgrastim, filgrastim-sndz, and filgrastim-aafi.

Regulatory & Marketing

Labeler Name
Sandoz Inc.
FDA Application #
BLA125553
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
03-06-2015
End Marketing Date
03-20-2023
Listing Expiration
03-20-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61314-246-71 identifies a specific commercial package of 1 vial in 1 carton / 1 ml in 1 vial of Zarxio, labeled by Sandoz Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sandoz Inc. on March 06, 2015. The current certification is valid through March 20, 2023.

What are the primary indications for this medication?

Filgrastim is a man-made version of a certain natural substance made in your body. It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Filgrastim is given to people whose ability to make white blood cells is reduced (for instance, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation). It is also used in certain treatment procedures (such as bone marrow/stem cell transplant). This monograph is about the following filgrastim products: filgrastim, tbo-filgrastim, filgrastim-sndz, and filgrastim-aafi.

How is this Sandoz Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61314024671. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61314-246-71
11-Digit CMS (5-4-2)
61314-0246-71

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.